# OnCo record osu-james (institution). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/institutions/osu-james/>
  a schema:MedicalOrganization ;
  onco:kind "institution" ;
  schema:identifier "osu-james" ;
  schema:name "The Ohio State University Comprehensive Cancer Center, James Cancer Hospital and Solove Research Institute"@en ;
  schema:alternateName "OSUCCC-James"@en, "The James"@en ;
  schema:description "Where John Byrd's team turned ibrutinib into the drug that transformed chronic lymphocytic leukaemia; Ohio State's NCI comprehensive centre."@en ;
  schema:url <https://onco.cc/institutions/osu-james/>, <https://cancer.osu.edu> ;
  schema:dateModified "2026-09-09"^^xsd:date ;
  schema:citation <https://cancer.osu.edu>, <https://cancer.osu.edu/for-patients-and-caregivers/clinical-trials>, <https://www.ptcog.site/index.php/facilities-in-operation-public> ;
  schema:addressCountry "US" ;
  schema:addressLocality "Columbus, OH" ;
  schema:latitude "39.994"^^xsd:decimal ;
  schema:longitude "-83.016"^^xsd:decimal ;
  onco:cancers <https://onco.cc/cancers/cll/>, <https://onco.cc/cancers/aml/>, <https://onco.cc/cancers/follicular-lymphoma/>, <https://onco.cc/cancers/sarcoma/> ;
  onco:technologies <https://onco.cc/technologies/kinase-inhibitors/>, <https://onco.cc/technologies/proton-therapy/>, <https://onco.cc/technologies/proton-therapy-systems/> ;
  onco:targets <https://onco.cc/targets/btk/>, <https://onco.cc/targets/bcl2/> ;
  onco:drugs <https://onco.cc/drugs/ibrutinib/>, <https://onco.cc/drugs/acalabrutinib/> ;
  onco:trials <https://onco.cc/trials/resonate/> ;
  onco:people <https://onco.cc/people/michael-caligiuri/>, <https://onco.cc/people/jennifer-woyach/> .